FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
216665NDASOLENO THERAP001VYKAT XRTABLET, EXTENDED RELEASE;ORAL25MGDIAZOXIDE CHOLINE2025-03-26PrescriptionNo
002VYKAT XRTABLET, EXTENDED RELEASE;ORAL75MGDIAZOXIDE CHOLINE2025-03-26PrescriptionNo
003VYKAT XRTABLET, EXTENDED RELEASE;ORAL150MGDIAZOXIDE CHOLINE2025-03-26PrescriptionYes